Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Surgery in adrenocortical carcinoma: Importance of national cooperation and centralized surgery.

Hermsen IG, Kerkhofs TM, den Butter G, Kievit J, van Eijck CH, Nieveen van Dijkum EJ, Haak HR; Dutch Adrenal Network.

Surgery. 2012 Jul;152(1):50-6. doi: 10.1016/j.surg.2012.02.005.

PMID:
22703895
2.

Surgical management and clinical prognosis of adrenocortical carcinoma.

Dong D, Li H, Yan W, Ji Z, Mao Q.

Urol Int. 2012;88(4):400-4. doi: 10.1159/000336134. Epub 2012 Apr 5.

PMID:
22487802
3.

Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data.

Kerkhofs TM, Verhoeven RH, Bonjer HJ, van Dijkum EJ, Vriens MR, De Vries J, Van Eijck CH, Bonsing BA, Van de Poll-Franse LV, Haak HR; Dutch Adrenal Network.

Eur J Endocrinol. 2013 Jun 7;169(1):83-9. doi: 10.1530/EJE-13-0142. Print 2013 Jul.

4.

Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.

Fassnacht M, Hahner S, Polat B, Koschker AC, Kenn W, Flentje M, Allolio B.

J Clin Endocrinol Metab. 2006 Nov;91(11):4501-4. Epub 2006 Aug 8.

PMID:
16895957
5.

Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.

Reibetanz J, Jurowich C, Erdogan I, Nies C, Rayes N, Dralle H, Behrend M, Allolio B, Fassnacht M; German ACC study group.

Ann Surg. 2012 Feb;255(2):363-9. doi: 10.1097/SLA.0b013e3182367ac3.

PMID:
22143204
6.

A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.

Abraham J, Bakke S, Rutt A, Meadows B, Merino M, Alexander R, Schrump D, Bartlett D, Choyke P, Robey R, Hung E, Steinberg SM, Bates S, Fojo T.

Cancer. 2002 May 1;94(9):2333-43.

7.

The role of surgery in the management of recurrent adrenocortical carcinoma.

Erdogan I, Deutschbein T, Jurowich C, Kroiss M, Ronchi C, Quinkler M, Waldmann J, Willenberg HS, Beuschlein F, Fottner C, Klose S, Heidemeier A, Brix D, Fenske W, Hahner S, Reibetanz J, Allolio B, Fassnacht M; German Adrenocortical Carcinoma Study Group.

J Clin Endocrinol Metab. 2013 Jan;98(1):181-91. doi: 10.1210/jc.2012-2559. Epub 2012 Nov 12.

PMID:
23150691
8.

Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.

Grubbs EG, Callender GG, Xing Y, Perrier ND, Evans DB, Phan AT, Lee JE.

Ann Surg Oncol. 2010 Jan;17(1):263-70. doi: 10.1245/s10434-009-0716-x. Epub 2009 Oct 23.

PMID:
19851811
9.

Adjuvant mitotane treatment for adrenocortical carcinoma.

Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A.

N Engl J Med. 2007 Jun 7;356(23):2372-80.

10.

Surgical resection of synchronously metastatic adrenocortical cancer.

Dy BM, Strajina V, Cayo AK, Richards ML, Farley DR, Grant CS, Harmsen WS, Evans DB, Grubbs EG, Bible KC, Young WF, Perrier ND, Que FG, Nagorney DM, Lee JE, Thompson GB.

Ann Surg Oncol. 2015 Jan;22(1):146-51. doi: 10.1245/s10434-014-3944-7. Epub 2014 Aug 5.

PMID:
25092161
11.

Operative intervention for recurrent adrenocortical cancer.

Dy BM, Wise KB, Richards ML, Young WF Jr, Grant CS, Bible KC, Rosedahl J, Harmsen WS, Farley DR, Thompson GB.

Surgery. 2013 Dec;154(6):1292-9; discussion 1299. doi: 10.1016/j.surg.2013.06.033.

PMID:
24238048
12.

Laparoscopic versus open surgery in stage I-III adrenocortical carcinoma -- a retrospective comparison of 32 patients.

Fosså A, Røsok BI, Kazaryan AM, Holte HJ, Brennhovd B, Westerheim O, Marangos IP, Edwin B.

Acta Oncol. 2013 Nov;52(8):1771-7. doi: 10.3109/0284186X.2013.765065. Epub 2013 Feb 11.

PMID:
23398621
13.

Resection of adrenocortical carcinoma liver metastasis: is it justified?

Gaujoux S, Al-Ahmadie H, Allen PJ, Gonen M, Shia J, D'Angelica M, Dematteo R, Fong Y, Blumgart L, Jarnagin WR.

Ann Surg Oncol. 2012 Aug;19(8):2643-51. doi: 10.1245/s10434-012-2358-7. Epub 2012 Apr 21.

PMID:
22526905
14.

The impact of tumor stage on prognosis in children with adrenocortical carcinoma.

Tucci S Jr, Martins AC, Suaid HJ, Cologna AJ, Reis RB.

J Urol. 2005 Dec;174(6):2338-42, discussion 2342.

PMID:
16280838
15.

Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experience.

Kemp CD, Ripley RT, Mathur A, Steinberg SM, Nguyen DM, Fojo T, Schrump DS.

Ann Thorac Surg. 2011 Oct;92(4):1195-200. doi: 10.1016/j.athoracsur.2011.05.013.

PMID:
21958764
16.

Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM.

JAMA Surg. 2016 Apr;151(4):365-73. doi: 10.1001/jamasurg.2015.4516.

17.

The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.

Wängberg B, Khorram-Manesh A, Jansson S, Nilsson B, Nilsson O, Jakobsson CE, Lindstedt S, Odén A, Ahlman H.

Endocr Relat Cancer. 2010 Feb 18;17(1):265-72. doi: 10.1677/ERC-09-0190. Print 2010 Mar.

18.

Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.

Fassnacht M, Johanssen S, Fenske W, Weismann D, Agha A, Beuschlein F, Führer D, Jurowich C, Quinkler M, Petersenn S, Spahn M, Hahner S, Allolio B; German ACC Registry Group.

J Clin Endocrinol Metab. 2010 Nov;95(11):4925-32. doi: 10.1210/jc.2010-0803. Epub 2010 Jul 28.

PMID:
20668036
19.

Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.

Tran TB, Liou D, Menon VG, Nissen NN.

Am Surg. 2013 Oct;79(10):1115-8.

PMID:
24160811
20.

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer.

Berruti A, Fassnacht M, Haak H, Else T, Baudin E, Sperone P, Kroiss M, Kerkhofs T, Williams AR, Ardito A, Leboulleux S, Volante M, Deutschbein T, Feelders R, Ronchi C, Grisanti S, Gelderblom H, Porpiglia F, Papotti M, Hammer GD, Allolio B, Terzolo M.

Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.

Supplemental Content

Support Center